Blue Jet Health

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0KBH01020
  • NSEID: BLUEJET
  • BSEID: 544009
INR
547.65
-7.75 (-1.4%)
BSENSE

Dec 05

BSE+NSE Vol: 1.96 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 40.17% vs 2.85% in Sep 2024

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is 49.08% vs 4.50% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 54.67% vs -6.44% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is 10,540.00% vs -44.44% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of Blue Jet Health With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
520.24
942.20
-421.96
-44.78%
Other Operating Income
0.00
0.00
0.00
Total Operating income
520.24
942.20
-421.96
-44.78%
Raw Material Cost
216.31
137.80
78.51
56.97%
Purchase of Finished goods
0.00
119.70
-119.70
-100.00%
(Increase) / Decrease In Stocks
24.45
191.70
-167.25
-87.25%
Employee Cost
35.98
98.70
-62.72
-63.55%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
67.56
127.50
-59.94
-47.01%
Total Expenditure (Excl Depreciation)
344.30
675.40
-331.10
-49.02%
Operating Profit (PBDIT) excl Other Income
175.94
266.80
-90.86
-34.06%
Other Income
32.53
12.00
20.53
171.08%
Operating Profit (PBDIT)
208.47
278.80
-70.33
-25.23%
Interest
5.32
0.70
4.62
660.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
203.15
278.10
-74.95
-26.95%
Depreciation
11.56
18.70
-7.14
-38.18%
Profit Before Tax
191.59
259.40
-67.81
-26.14%
Tax
48.28
70.40
-22.12
-31.42%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
143.31
189.00
-45.69
-24.17%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
143.31
189.00
-45.69
-24.17%
Equity Capital
34.69
23.00
11.69
50.83%
Face Value
2.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
8.26
82.17
-73.91
-89.95%
Diluted Earnings per share
8.26
82.07
-73.81
-89.94%
Operating Profit Margin (Excl OI)
33.82%
28.32%
0.00
5.50%
Gross Profit Margin
39.05%
29.52%
0.00
9.53%
PAT Margin
27.55%
20.06%
0.00
7.49%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 520.24 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 40.17% vs 2.85% in Sep 2024

Half Yearly - Standalone Net Profit
Standalone Net Profit 143.31 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 49.08% vs 4.50% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 175.94 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 54.67% vs -6.44% in Sep 2024

Half Yearly - Interest
Interest 5.32 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 10,540.00% vs -44.44% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 33.82%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024